Digistain

Seed
digistain.co.uk Biotech & Healthcare London, United Kingdom 40 employees
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Jun 4, 2026
Investors 1 Backer
Decision Makers 4 Verified

About Digistain

Digistain uses infrared scanning to determine which breast cancer patients are fit for chemotherapy.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters London, United Kingdom
Team Size 40 employees
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website digistain.co.uk
Domain Registered Date Oct 3, 2016

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Seed announced

  2. Milestone

    Website domain registered

    digistain.co.uk

Investors & Backers

1
Y Combinator

Funding History

2 Rounds
Seed · Jun 4, 2026
Undisclosed
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

2

Christopher Phillips

Founder

Work email & phone locked Unlock →

Hemmel Amrania

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts